An end to AIDS in children, achieved through a strong, strategic, and action-oriented alliance of multisectoral stakeholders at national, regional, and global levels that works with women children and adolescents living with HIV, national governments, and partners to mobilize leadership, funding...
This research discusses how PrEP was approved for HIV prevention in the US in 2012; uptake has been slow. Black and Hispanic people have higher rates of new HIV diagnoses than White non-Hispanic people in the US. We describe the inequitable use of PrEP by race within US regions from 2012-2021.
HIVMA created this document as a reference for HIV clinicians and educators across the trainee and provider continuum to help improve the delivery of HIV care and prevention. The resources include guidelines, clinical decision-making tools, continuing education opportunities, provider directories...
This page offers considerations for the care of people with HIV, including prevention and treatment of monkeypox.
The webinar series focused on best practices and strategies for effectively using HIV data for successful programmatic and systematic outcomes in state, local, territorial, and tribal (STLT) health departments. The first webinar focused on data reporting to multiple funding streams. The second...
This brochure presents guidance to limit liver toxicity in the HIV-positive patient with latent TB infection.
HIV is an infection that breaks down your immune system and can lead to AIDS. There’s no cure, but treatment can help you stay healthy.
This report is the annual compilation of data from World Health Organization’s (WHO) 193 member states. It provides a summary of the current status of national health and health systems, including mortality and burden of disease, causes of death, reported infectious diseases, health service coverage...
